Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia

The majority of adult patients affected by B-cell acute lymphoblastic leukemia (B-ALL) will relapse after an initial response, while approximately 20% will display primary resistant disease. Patients suffering from relapsed/refractory B-ALL have a very poor outcome. Allogeneic hematopoietic cell tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Maffini, Enrico, Saraceni, Francesco, Lanza, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432388/
https://www.ncbi.nlm.nih.gov/pubmed/34595415
http://dx.doi.org/10.2991/chi.d.190503.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432388/
https://www.ncbi.nlm.nih.gov/pubmed/34595415
http://dx.doi.org/10.2991/chi.d.190503.002

Ejemplares similares